FRESENIUS MEDICAL CARE AG |
Market Closed -
Other stock markets
|
After market 03:33:51 pm | |||
| 39.6 EUR | -2.20% |
|
39.63 | +0.08% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 19.57B 21.26B | Sales 2025 * | 20.32B 22.06B | Capitalization | 11.88B 12.9B |
|---|---|---|---|---|---|
| Net income 2024 * | 651M 707M | Net income 2025 * | 964M 1.05B | EV / Sales 2024 * | 1.11 x |
| Net Debt 2024 * | 9.92B 10.77B | Net Debt 2025 * | 8.98B 9.75B | EV / Sales 2025 * | 1.03 x |
| P/E ratio 2024 * |
18.9
x | P/E ratio 2025 * |
12.4
x | Employees | 117,128 |
| Yield 2024 * |
2.66% | Yield 2025 * |
3.22% | Free-Float | 67.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Fresenius Medical Care AG
More recommendations
More press releases
More news
| 1 day | -2.19% | ||
| 1 week | -3.72% | ||
| Current month | +0.05% | ||
| 1 month | +1.64% | ||
| 3 months | +11.23% | ||
| 6 months | +10.39% | ||
| Current year | +4.37% |
1 week
39.23
42.12
1 month
36.5742.12
Current year
33.8842.12
1 year
30.1649.62
3 years
25.9571.14
5 years
25.9581.10
10 years
25.9593.82
| Managers | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 56 | 19-10-31 |
Martin Fischer
DFI | Director of Finance/CFO | 47 | 23-09-30 |
Franklin Maddux
CTO | Chief Tech/Sci/R&D Officer | 65 | 08-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 16-05-11 |
Shervin Korangy
BRD | Director/Board Member | 50 | 23-07-13 |
Marcus Kuhnert
BRD | Director/Board Member | 56 | 23-07-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.48% | 202 M€ | -.--% | ||
| 1.12% | 2 M€ | +13.56% | - | |
| 0.80% | 79 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-21 | 39.6 | -2.20% | 447 946 |
| 24-05-20 | 40.49 | +0.07% | 236,272 |
| 24-05-17 | 40.46 | -3.02% | 439,279 |
| 24-05-16 | 41.72 | -0.81% | 786,412 |
| 24-05-15 | 42.06 | +2.21% | 649,796 |
Delayed Quote Xetra, May 21, 2024 at 11:00 am EDT
More quotes
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
2024-07-29
- Q2 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
40.49
EUR
Average target price
39.84
EUR
Spread / Average Target
-1.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.37% | 12.9B | |
| +18.36% | 85.14B | |
| -27.86% | 72.06B | |
| +2.75% | 27.07B | |
| -9.16% | 17.43B | |
| -1.92% | 16.98B | |
| +3.92% | 16.02B | |
| +8.62% | 13.87B | |
| +70.35% | 13.06B | |
| +72.90% | 12.79B |
- Stock Market
- Equities
- FME Stock